Investment Rating - The investment rating for the company is "Buy" (maintained) [2][12]. Core Insights - The company is focused on becoming a supplier of humanoid robot "limbs" and has reported a significant increase in net profit by 494% year-on-year for 2024 [1][9]. - The company achieved a revenue of 7.13 billion yuan in 2024, representing a year-on-year growth of 18.4% [7][10]. - The projected net profit for Q1 2025 is estimated to be between 69 million to 75 million yuan, indicating a year-on-year growth of 32% to 43% [7][10]. - The company has established a wholly-owned subsidiary, Martin Robotics, to accelerate its entry into the humanoid robot components market [9]. Financial Summary - The total market capitalization of the company is 166.66 billion yuan, with a circulating market capitalization of 120.09 billion yuan [3]. - The company's earnings per share (EPS) for 2024 is projected at 2.04 yuan, with estimates of 3.22 yuan for 2025 and 4.84 yuan for 2026 [10][14]. - The company’s revenue is expected to grow to 9.15 billion yuan in 2025, with a year-on-year growth rate of 28.4% [10][14]. - The gross profit margin for 2024 is reported at 13.9%, with projections of 13.4% for 2025 and 14.1% for 2026 [10][14].
震裕科技：公司信息更新报告：2024年净利润同比大增494%，致力成为人形机器人“肢体”供应商-20250423